{"id":"https://openalex.org/W3199767258","doi":"https://doi.org/10.35248/2161-0495.21.s18.002","title":"In vitro Inactivation of SARS-Cov-2 by Povidone-Iodine In situ Gel FormingSolution","display_name":"In vitro Inactivation of SARS-Cov-2 by Povidone-Iodine In situ Gel FormingSolution","publication_year":2021,"publication_date":"2021-01-01","ids":{"openalex":"https://openalex.org/W3199767258","doi":"https://doi.org/10.35248/2161-0495.21.s18.002","mag":"3199767258"},"language":"en","primary_location":{"id":"mag:3199767258","doi":"https://doi.org/10.35248/2161-0495.21.s18.002","is_oa":true,"landing_page_url":"https://www.longdom.org/open-access/in-vitro-inactivation-of-sarscov2-by-povidoneiodine-in-situ-gel-formingsolution.pdf","pdf_url":null,"source":{"id":"https://openalex.org/S2764848300","display_name":"Journal of Clinical Toxicology","issn_l":"2161-0495","issn":["2161-0495"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":"https://openalex.org/P4310320466","host_organization_name":"OMICS Publishing Group","host_organization_lineage":["https://openalex.org/P4310320466"],"host_organization_lineage_names":["OMICS Publishing Group"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Journal of Clinical Toxicology","raw_type":null},"volume":null,"type":"article","indexed_in":[],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://www.longdom.org/open-access/in-vitro-inactivation-of-sarscov2-by-povidoneiodine-in-situ-gel-formingsolution.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5043491695","display_name":"Bo Liang","orcid":"https://orcid.org/0000-0002-1450-4002","observed_orcids":["https://orcid.org/0000-0002-1450-4002"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Bo Liang","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-1450-4002","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103116892","display_name":"Xudong Yuan","orcid":"https://orcid.org/0000-0003-1989-7332","observed_orcids":["https://orcid.org/0000-0003-1989-7332"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Xudong Yuan","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-1989-7332","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053586216","display_name":"Gang Wei","orcid":"https://orcid.org/0000-0002-9600-0982","observed_orcids":["https://orcid.org/0000-0002-9600-0982"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gang Wei","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-9600-0982","affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Wei Wang","orcid":"https://orcid.org/0000-0002-1430-1360","observed_orcids":["https://orcid.org/0000-0002-1430-1360"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Wei Wang","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-1430-1360","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100710641","display_name":"Ming Zhang","orcid":"https://orcid.org/0000-0001-6780-7843","observed_orcids":["https://orcid.org/0000-0001-6780-7843"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ming Zhang","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-6780-7843","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068437628","display_name":"Haizhou Peng","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Haizhou Peng","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072414645","display_name":"Juan Carlos Hernaiz\u2010Leonardo","orcid":"https://orcid.org/0000-0002-3013-2683","observed_orcids":["https://orcid.org/0000-0002-3013-2683"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Juan C. Hernaiz-Leonardo","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110438148","display_name":"Amin R. Javer","orcid":"https://orcid.org/0000-0003-3116-6559","observed_orcids":["https://orcid.org/0000-0003-3116-6559"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Amin Javer","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-3116-6559","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112302097","display_name":"Michelle Mendenhall","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michelle Mendenhall","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042555934","display_name":"Justin Jul","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Justin Jul","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080825493","display_name":"er","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"er","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071840045","display_name":"Sammi Huang","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sammi Huang","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073329501","display_name":"Hany Michail","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hany Michail","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063720832","display_name":"Yong Lu","orcid":"https://orcid.org/0000-0003-0077-0040","observed_orcids":["https://orcid.org/0000-0003-0077-0040","https://orcid.org/0000-0001-8522-617X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yong Lu","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-0077-0040","affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Qi Zhu","orcid":"https://orcid.org/0000-0001-5497-9478","observed_orcids":["https://orcid.org/0000-0001-5497-9478"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Qi Zhu","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-5497-9478","affiliations":[]},{"author_position":"last","author":{"id":null,"display_name":"John J. Baldwin","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"John J. Baldwin","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.10903057,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"1","last_page":"4"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12526","display_name":"Antimicrobial agents and applications","score":0.2619999945163727,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T12526","display_name":"Antimicrobial agents and applications","score":0.2619999945163727,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10118","display_name":"SARS-CoV-2 and COVID-19 Research","score":0.20350000262260437,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":0.1599999964237213,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/povidone-iodine","display_name":"povidone-iodine","score":0.9419999718666077},{"id":"https://openalex.org/keywords/sars-cov-2","display_name":"SARS-CoV-2","score":0.9750000238418579},{"id":"https://openalex.org/keywords/virucidal-activity","display_name":"virucidal activity","score":0.8579999804496765},{"id":"https://openalex.org/keywords/nasal-spray","display_name":"nasal spray","score":0.7210000157356262},{"id":"https://openalex.org/keywords/log-reduction","display_name":"log reduction","score":0.5899999737739563},{"id":"https://openalex.org/keywords/toxicity","display_name":"toxicity","score":0.42800000309944153},{"id":"https://openalex.org/keywords/covid-19-treatment","display_name":"COVID-19 treatment","score":0.7020000219345093}],"concepts":[{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.7727510929107666},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.6620370149612427},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.5293636322021484},{"id":"https://openalex.org/C138944611","wikidata":"https://www.wikidata.org/wiki/Q1163287","display_name":"Clearance","level":2,"score":0.5162298679351807},{"id":"https://openalex.org/C3007834351","wikidata":"https://www.wikidata.org/wiki/Q82069695","display_name":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)","level":5,"score":0.4684945046901703},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.466875284910202},{"id":"https://openalex.org/C184112429","wikidata":"https://www.wikidata.org/wiki/Q476174","display_name":"Serial dilution","level":3,"score":0.456196129322052},{"id":"https://openalex.org/C539932907","wikidata":"https://www.wikidata.org/wiki/Q1103","display_name":"Iodine","level":2,"score":0.45124101638793945},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.39313018321990967},{"id":"https://openalex.org/C3008058167","wikidata":"https://www.wikidata.org/wiki/Q84263196","display_name":"Coronavirus disease 2019 (COVID-19)","level":4,"score":0.3711008131504059},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.36640465259552},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.33560341596603394},{"id":"https://openalex.org/C43617362","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Chromatography","level":1,"score":0.32971012592315674},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.14880263805389404},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.10375633835792542},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.0},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C524204448","wikidata":"https://www.wikidata.org/wiki/Q788926","display_name":"Infectious disease (medical specialty)","level":3,"score":0.0},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:3199767258","doi":"https://doi.org/10.35248/2161-0495.21.s18.002","is_oa":true,"landing_page_url":"https://www.longdom.org/open-access/in-vitro-inactivation-of-sarscov2-by-povidoneiodine-in-situ-gel-formingsolution.pdf","pdf_url":null,"source":{"id":"https://openalex.org/S2764848300","display_name":"Journal of Clinical Toxicology","issn_l":"2161-0495","issn":["2161-0495"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":"https://openalex.org/P4310320466","host_organization_name":"OMICS Publishing Group","host_organization_lineage":["https://openalex.org/P4310320466"],"host_organization_lineage_names":["OMICS Publishing Group"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Journal of Clinical Toxicology","raw_type":null}],"best_oa_location":{"id":"mag:3199767258","doi":"https://doi.org/10.35248/2161-0495.21.s18.002","is_oa":true,"landing_page_url":"https://www.longdom.org/open-access/in-vitro-inactivation-of-sarscov2-by-povidoneiodine-in-situ-gel-formingsolution.pdf","pdf_url":null,"source":{"id":"https://openalex.org/S2764848300","display_name":"Journal of Clinical Toxicology","issn_l":"2161-0495","issn":["2161-0495"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":"https://openalex.org/P4310320466","host_organization_name":"OMICS Publishing Group","host_organization_lineage":["https://openalex.org/P4310320466"],"host_organization_lineage_names":["OMICS Publishing Group"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Journal of Clinical Toxicology","raw_type":null},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9537000060081482}],"sustainable_development_goals_aurora":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.44999998807907104}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3045533969","https://openalex.org/W3085641160","https://openalex.org/W3202412439","https://openalex.org/W3126643242","https://openalex.org/W4211024322","https://openalex.org/W3094275942","https://openalex.org/W4200436256","https://openalex.org/W3087428803","https://openalex.org/W3180843689","https://openalex.org/W4312212974"],"abstract_inverted_index":{"Background:":[0],"Povidone":[1],"Iodine":[2],"(PVP-I)":[3],"nasal":[4,18,155],"solutions":[5,26],"are":[6,13],"effective":[7],"against":[8,58,101],"the":[9,17,41,59,75,88,113,144,161,172,182,189],"SARS-CoV-2":[10,60,207,234],"virus,":[11],"but":[12],"cleared":[14],"rapidly":[15,157],"from":[16],"cavity,":[19],"limiting":[20],"its":[21,64],"use.":[22],"PVP-I":[23,48,76,150,153,173,186,202],"gel":[24,55,77,203],"forming":[25,56,78,204],"can":[27],"circumvent":[28],"this":[29,185],"problem":[30],"due":[31],"to":[32,97,122,142],"their":[33],"higher":[34,220],"viscosity":[35],"and":[36,62,85],"prolonged":[37],"clearing":[38],"time.\r\n\r\nObjective:":[39],"Characterize":[40],"in":[42,53,104,117,198,208,228],"vitro":[43,209],"virucidal":[44,99],"activity":[45,100,109],"of":[46,74,87,115,148,164,181,213],"long-acting":[47],"compositions":[49],"developed":[50],"using":[51,66,136],"an":[52],"situ":[54],"technology":[57],"virus":[61,116,123,183],"test":[63,119],"safety":[65],"a":[67,126,132,149,229],"rat":[68],"model.\r\n\r\nMethods:":[69],"We":[70,130],"tested":[71],"different":[72],"dilutions":[73],"solution\u2013":[79],"full":[80],"concentration,":[81],"90%,":[82],"50%,":[83],"28%":[84],"9%":[86],"original":[89],"formulation":[90,187],"concentration":[91],"\u2013":[92],"at":[93,188,219],"varying":[94],"exposure":[95,221],"times":[96],"assess":[98],"SARSCoV-":[102],"2":[103],"VERO76":[105,165],"cells":[106],"infected.":[107],"Virucidal":[108],"was":[110,169,177,196],"recorded":[111],"as":[112,125],"reduction":[114,128],"formulation-treated":[118],"wells":[120],"compared":[121],"controls":[124],"log":[127],"value.":[129],"conducted":[131],"28-day":[133],"toxicity":[134,147,168,195],"study":[135],"Sprague":[137],"Dawley":[138],"CD\u00ae":[139],"IGS":[140],"rats":[141],"determine":[143],"potential":[145],"delayed":[146,194],"formulation.\r\n\r\nResults:":[151],"The":[152],"gel-forming":[154],"spray":[156],"inactivated":[158],"SARS-CoV-2,":[159],"inhibiting":[160],"viral":[162],"infection":[163],"cells.":[166],"No":[167,193],"observed":[170,197],"for":[171,232],"formulations.":[174],"Significant":[175],"inactivation":[176],"noted":[178],"with":[179,184,215],"preincubation":[180],"lowest":[190],"concentrations":[191],"tested.":[192],"our":[199],"animal":[200],"model.\r\n\r\nConclusions:":[201],"formulations":[205,224],"inactivate":[206],"within":[210],"30":[211],"seconds":[212],"exposure,":[214],"increasing":[216],"effects":[217],"seen":[218],"times.":[222],"These":[223],"could":[225],"prove":[226],"useful":[227],"clinical":[230],"setting":[231],"managing":[233],"infected":[235],"patients.":[236]},"counts_by_year":[],"updated_date":"2026-10-28T10:33:24.094632","created_date":"2021-09-27T00:00:00"}